Cargando…
Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations
Pharmacophore models are widely used for the identification of promising primary hits in compound large libraries. Recent studies have demonstrated that pharmacophores retrieved from protein-ligand molecular dynamic trajectories outperform pharmacophores retrieved from a single crystal complex struc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929024/ https://www.ncbi.nlm.nih.gov/pubmed/31757043 http://dx.doi.org/10.3390/ijms20235834 |
_version_ | 1783482608720543744 |
---|---|
author | Polishchuk, Pavel Kutlushina, Alina Bashirova, Dayana Mokshyna, Olena Madzhidov, Timur |
author_facet | Polishchuk, Pavel Kutlushina, Alina Bashirova, Dayana Mokshyna, Olena Madzhidov, Timur |
author_sort | Polishchuk, Pavel |
collection | PubMed |
description | Pharmacophore models are widely used for the identification of promising primary hits in compound large libraries. Recent studies have demonstrated that pharmacophores retrieved from protein-ligand molecular dynamic trajectories outperform pharmacophores retrieved from a single crystal complex structure. However, the number of retrieved pharmacophores can be enormous, thus, making it computationally inefficient to use all of them for virtual screening. In this study, we proposed selection of distinct representative pharmacophores by the removal of pharmacophores with identical three-dimensional (3D) pharmacophore hashes. We also proposed a new conformer coverage approach in order to rank compounds using all representative pharmacophores. Our results for four cyclin-dependent kinase 2 (CDK2) complexes with different ligands demonstrated that the proposed selection and ranking approaches outperformed the previously described common hits approach. We also demonstrated that ranking, based on averaged predicted scores obtained from different complexes, can outperform ranking based on scores from an individual complex. All developments were implemented in open-source software pharmd. |
format | Online Article Text |
id | pubmed-6929024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69290242019-12-26 Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations Polishchuk, Pavel Kutlushina, Alina Bashirova, Dayana Mokshyna, Olena Madzhidov, Timur Int J Mol Sci Article Pharmacophore models are widely used for the identification of promising primary hits in compound large libraries. Recent studies have demonstrated that pharmacophores retrieved from protein-ligand molecular dynamic trajectories outperform pharmacophores retrieved from a single crystal complex structure. However, the number of retrieved pharmacophores can be enormous, thus, making it computationally inefficient to use all of them for virtual screening. In this study, we proposed selection of distinct representative pharmacophores by the removal of pharmacophores with identical three-dimensional (3D) pharmacophore hashes. We also proposed a new conformer coverage approach in order to rank compounds using all representative pharmacophores. Our results for four cyclin-dependent kinase 2 (CDK2) complexes with different ligands demonstrated that the proposed selection and ranking approaches outperformed the previously described common hits approach. We also demonstrated that ranking, based on averaged predicted scores obtained from different complexes, can outperform ranking based on scores from an individual complex. All developments were implemented in open-source software pharmd. MDPI 2019-11-20 /pmc/articles/PMC6929024/ /pubmed/31757043 http://dx.doi.org/10.3390/ijms20235834 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Polishchuk, Pavel Kutlushina, Alina Bashirova, Dayana Mokshyna, Olena Madzhidov, Timur Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations |
title | Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations |
title_full | Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations |
title_fullStr | Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations |
title_full_unstemmed | Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations |
title_short | Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations |
title_sort | virtual screening using pharmacophore models retrieved from molecular dynamic simulations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929024/ https://www.ncbi.nlm.nih.gov/pubmed/31757043 http://dx.doi.org/10.3390/ijms20235834 |
work_keys_str_mv | AT polishchukpavel virtualscreeningusingpharmacophoremodelsretrievedfrommoleculardynamicsimulations AT kutlushinaalina virtualscreeningusingpharmacophoremodelsretrievedfrommoleculardynamicsimulations AT bashirovadayana virtualscreeningusingpharmacophoremodelsretrievedfrommoleculardynamicsimulations AT mokshynaolena virtualscreeningusingpharmacophoremodelsretrievedfrommoleculardynamicsimulations AT madzhidovtimur virtualscreeningusingpharmacophoremodelsretrievedfrommoleculardynamicsimulations |